Search This Blog

Wednesday, May 6, 2020

Vanda Pharmaceuticals EPS beats by $0.01, beats on revenue

Vanda Pharmaceuticals (NASDAQ:VNDA): Q1 GAAP EPS of $0.01 beats by $0.01.
Revenue of $58M (+21.5% Y/Y) beats by $0.58M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)